Abstract: Described herein are systems, methods, and media for managing streaming devices using machine learning models. In an embodiment, a method of managing streaming devices includes detecting that a streaming application is launched on a streaming device; recommending a set of software components for the streaming device, wherein the set of recommended software components includes the streaming application; determining a set of software components that are actually running on the streaming device; and closing at least one of the software components that are actually running but not in the set of recommended software components.

Abstract: The present invention relates to an immobilized deacylase in cross-linked cell aggregates, a preparation method and use thereof in deacylation of echinocandins. The immobilization of deacylase in cross-linked cell aggregates comprises the step of Production of Deacylase by fermentation Aggregation of cells Cross-linking of the cells. Present invention also relates to the use of the cross-linked cell aggregates of deacylase in deacylation of Echinocandin intermediates.

Abstract: An illustrative method includes detecting a request to perform a cluster-wide snapshot of a cluster comprising one or more nodes on which one or more containerized applications are deployed, the snapshot corresponding to a point in time; preparing, based on the request, objects within the cluster for the snapshot; and generating, in response to the preparing, the cluster-wide snapshot of the cluster.

Abstract: Presented herein are methods, non-transitory computer readable media, and devices for integrating a hybrid model of fine-grained locking and data-partitioning wherein fine-grained locking is added to existing systems that are based on hierarchical data-partitioning in order in increase parallelism with minimal code re-write.

Abstract: A method of treating cancer includes a combination of a therapeutically effective amount of an illudin or an illudin analog thereof, derivative, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of a spironolactone or an analog, derivative, or a pharmaceutically acceptable salt thereof. Compositions and kits of the same are included herein.

Abstract: An example system can include: at least one processor; and non-transitory computer-readable storage storing instructions that, when executed by the at least one processor, cause the system to: generate an ingestion manager programmed to ingest data associated with a job; and generate a logging manager programmed to capture metadata associated with the job; wherein the ingestion manager is programmed to automatically retry the job based upon the metadata captured by the logging manager.

Abstract: This application discloses methods for treating a cancer that has metastasized to the brain in a subject using a therapeutically effective amount of HydroxyUreaMethyl Acylfulvene. In addition, pharmaceutical compositions having HydroxyUreaMethyl Acylfulvene and a pharmaceutically acceptably carrier, diluent, excipient, or a combination thereof are disclosed.

Abstract: Presented herein are methods, non-transitory computer readable media, and devices for optimizing thread assignment to schedulers, avoid starvation of individual data partitions, and maximize parallelism in the presence of hierarchical data partitioning are disclosed, which include: partitioning, by a network storage server, a scheduler servicing a data partitioned system into a plurality of autonomous schedulers; determining what fraction of thread resources in the data partitioned system at least one of the plurality of autonomous schedulers is to receive; and determining, with minimal synchronization, when it is time to allow the at least one of the plurality of autonomous schedulers servicing a coarse hierarchy to run.

Abstract: A method of treating cancer includes a combination of a therapeutically effective amount of an illudin or an illudin analog thereof, derivative, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of a PARP inhibitor or an analog, derivative, or a pharmaceutically acceptable salt thereof. Compositions and kits of the same are included herein.

Abstract: Techniques are disclosed for measuring a concentration of an analyte in a subject based on reflectance spectra obtained from the subject. The spectra are obtained while and/or before and/or after photoreactions are induced in the subject, where the photoreactions change the reflectivity of the subject. The rate of change of the reflectivity is correlated with the concentration of the analyte.

Abstract: An example method for automated elastic resource management of a container system by a storage system comprises providing, by a container storage management system, a volume for use by a containerized application of a container system, the volume deployed on a node of the container system; analyzing, by the container storage management system, incoming input/output (I/O) operations to the volume; and adjusting, by the container storage management system and based on the analyzing, a capacity of a resource associated with the node.

Abstract: Presented herein are methods, non-transitory computer readable media, and devices for integrating a hybrid model of fine-grained locking and data-partitioning wherein fine-grained locking is added to existing systems that are based on hierarchical data-partitioning in order in increase parallelism with minimal code re-write.

Abstract: A method for determining a microstructure of a coating on a component. The method includes projecting at least a first electromagnetic signal in a first plane of polarization onto the coating and a second electromagnetic signal in a second plane of polarization onto the coating. A first and second time delay can be determined. The microstructure of the coating is based on a difference between at least two time delays.

Abstract: Techniques are disclosed for measuring a concentration of an analyte in a subject based on reflectance spectra obtained from the subject. The spectra are obtained while and/or before and/or after photoreactions are induced in the subject, where the photoreactions change the reflectivity of the subject. The rate of change of the reflectivity is correlated with the concentration of the analyte.

Abstract: A method for treating a subject in need thereof having a bone or blood cancer, or a cancer that metastasizes to bone that includes administering to the subject an effective amount of hydroxyureamethyl acylfulvene.

Abstract: An example method for provisioning volumes in a distributed storage system comprises: receiving a volume provision request to allocate data storage space for a storage volume on a storage node cluster comprising a plurality of storage nodes; determining, in response to the volume provision request, locations of replicas of other storage volumes on the plurality of storage nodes; determining, based on the locations of the replicas of the other storage volumes, a placement of replicas of the storage volume on a set of storage nodes of the plurality of storage nodes that minimizes a number of failed storage volumes in an event of a failure of the set of storage nodes; and provisioning, based on the determining the placement, the storage volume on the set of storage nodes.

Abstract: The methods include treating atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene. Some embodiments relate to treatment of atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene to a population or subject expressing SMARCB1.

Abstract: An illustrative method includes detecting a request to perform a cluster-wide snapshot of a cluster comprising one or more nodes on which one or more containerized applications are deployed, the snapshot corresponding to a point in time; preparing, based on the request, objects within the cluster for the snapshot; and generating, in response to the preparing, the cluster-wide snapshot of the cluster.

Abstract: The methods include treating atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene. Some embodiments relate to treatment of atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene to a population or subject expressing SMARCB1.

Abstract: This application relates to markers for use in the determination of the sensitivity of a cancer patient to an anti-cancer agent (e.g., illudins/illudin analogs) to be administered thereto, which markers can determine whether or not the cancer of the patient has a therapeutic response to the anti-cancer agent, and to application of the markers.